CARD8 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.869200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.642200E-01
Normal-vs-Stage2
3.908400E-01
Normal-vs-Stage3
3.433000E-01
Normal-vs-Stage4
4.146800E-01
Stage1-vs-Stage2
5.626800E-01
Stage1-vs-Stage3
6.588600E-01
Stage1-vs-Stage4
3.953800E-01
Stage2-vs-Stage3
3.969600E-01
Stage2-vs-Stage4
7.426400E-01
Stage3-vs-Stage4
2.212800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.863400E-01
Normal-vs-AfricanAmerican
4.040800E-01
Normal-vs-Asian
3.590800E-01
Caucasian-vs-AfricanAmerican
7.509000E-01
Caucasian-vs-Asian
1.410830E-01
AfricanAmerican-vs-Asian
1.813220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.773200E-01
Normal-vs-Female
3.998200E-01
Male-vs-Female
2.097400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.554000E-01
Normal-vs-Age(41-60Yrs)
4.067800E-01
Normal-vs-Age(61-80Yrs)
3.796200E-01
Normal-vs-Age(81-100Yrs)
3.782200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.705600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.931000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.891600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.783820E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.826400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.447200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.728400E-01
Normal-vs-Daily Drinker
3.562200E-01
Normal-vs-Weekly Drinker
3.664400E-01
Normal-vs-Occasional Drinker
3.794400E-01
Normal-vs-Social Drinker
4.015000E-01
Non Drinker-vs-Daily Drinker
6.195000E-01
Non Drinker-vs-Weekly Drinker
8.417600E-01
Non Drinker-vs-Occasional Drinker
8.116200E-01
Non Drinker-vs-Social Drinker
5.123800E-01
Daily Drinker-vs-Weekly Drinker
7.056200E-01
Daily Drinker-vs-Occasional Drinker
3.868400E-01
Daily Drinker-vs-Social Drinker
2.269800E-01
Weekly Drinker-vs-Occasional Drinker
5.795000E-01
Weekly Drinker-vs-Social Drinker
3.509000E-01
Occasional Drinker-vs-Social Drinker
5.751600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.023800E-01
Normal-vs-Grade 2
2.716600E-01
Normal-vs-Grade 3
3.165000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.563400E-01
Grade 1-vs-Grade 3
9.725000E-01
Grade 1-vs-Grade 4
5.023800E-01
Grade 2-vs-Grade 3
5.282200E-01
Grade 2-vs-Grade 4
2.716600E-01
Grade 3-vs-Grade 4
3.165000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.855800E-01
Normal-vs-NonDiabetic
3.723400E-01
Diabetic-vs-NonDiabetic
5.693800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.359200E-01
Normal-vs-NoPancreatitis
3.802200E-01
Pancreatitis-vs-NoPancreatitis
2.886400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.840800E-01
Normal-vs-N1
3.905400E-01
N0-vs-N1
7.329000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.957400E-01
Normal-vs-TP53-NonMutant
3.359600E-01
TP53-Mutant-vs-TP53-NonMutant
7.145800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
